Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes. - Foltyn-Dumitru M; Banan R; Schell M; Mahmutoglu MA; Kessler T; Wick W; Brugnara G; Bendszus M; Sahm F; Vollmuth P (Neuro-oncology, 2025)